DEA Schedule CV
Strength
10 mg/mL
Manufacturer
UCB, Inc.NDC
50474087015
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
BRIVARACETAMApproval Type
New Drug (NDA)
FDA Application
NDA205838On Market Since
5/12/2016
Pharmacological Classes
Epoxide Hydrolase Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.